The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.本揭示內容係關於治療C型肝炎病毒(HCV)感染之化合物,組合物及方法。亦揭示者為含有此種化合物之醫藥組合物,及使用此等化合物以治療HCV感染之方法。